ArticleLancet regional health. Americas2025
A systematic review and meta-analysis of Tobacco 21 policies and youth tobacco use: implications for future policy research.
Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Tobacco and cannabis use in the young 'Not in Employment, Education or Training' population: A systematic review and meta-analysis.Addiction (Abingdon, England) · 2026Pooled it
- Quantifying the evidence and burden of smoking behaviour on tuberculosis incidence among adult population: a systematic review and meta-analysis.Journal of global health · 2026Pooled it
- The UK's Tobacco and Vapes Act puts the end of smoking within reach, but the job is not done.The Lancet regional health. Europe · 2026Article
- State-Level Flavored E-Cigarette Bans and Initiation Rates Among Youths and Adults.JAMA network open · 2026Article
- Differential predictors of smoking quit attempts between single- and poly-tobacco-using adolescents: a Korean national survey analysis.Frontiers in public health · 2026Article
- Expanding the evidence base: The impact of Tobacco 21 policies on youth tobacco use.Tobacco prevention & cessation · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Raising the sales age to 21 is among the most important steps to curb tobacco/nicotine use in youth in the past two decades. The study aims to systematically review and perform meta-analyses on the impact of Tobacco 21 (T21) policies on tobacco use among 11-to-20-year-olds in the United States, encompassing T21s at local, state, and national levels. Methods: We screened 14 databases following PRISMA and PICOS criteria, applying standardized abstraction forms and quality assessment tools. Inverse-variance-weighted random-effects models estimated pooled, fully adjusted odds ratios (ORs) for tobacco use outcomes, with moderation analyses by T21-level, gender, age, and race/ethnicity proportions. Sensitivity analyses considering study quality and study-level clusters were conducted. Findings: Among 24 studies included, T21s were associated with current cigarette (OR = 0.92, 95% CI: 0.77-1.11), chewing tobacco (OR = 0.89, 95% CI: 0.65-1.23), e-cigarette (OR = 1.32, 95% CI: 0.88-1.97), and cigar/cigarillo use (OR = 0.98, 95% CI: 0.55-1.73) compared to non-T21 areas and pre-T21 periods. Moderation analyses showed that studies on the Federal T21 and studies with fewer female participants (<50%) had significantly lower odds of cigarette use; No significant moderation effects by race/ethnicity or age-group. Interpretation: Almost all meta-analyses had null findings, suggesting null policy effects on reducing the prevalence of youth tobacco use. There is evidence that the policy level and gender proportion in studies moderated T21 effects. Future research and practice should consider policy levels, youth age ranges, analytic strategies, and implementation factors such as ID verification and compliance check inspections that may improve T21's effectiveness in reducing youth tobacco use. Funding: No funding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.